Nucleolar disruption leads to the spatial separation of key 18S rRNA processing factors

Amy Jane Turner1, Andrew Alexander Knox, Nicholas James Watkins

  • 1Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK.

RNA Biology
|March 16, 2012
PubMed

Insights

Chemotherapy drugs disrupt nucleoli and block ribosome production by affecting the small subunit (SSU) processome. Different drugs impact SSU processome formation and localization uniquely, impacting cell cycle arrest and apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Chemotherapeutic agents often induce nucleolar disruption and inhibit ribosome production, leading to p53 stabilization, cell cycle arrest, or apoptosis.
  • The precise mechanisms by which these drugs disrupt nucleoli and block ribosome biogenesis remain unclear.
  • The small subunit (SSU) processome, crucial for 18S rRNA processing and small ribosomal subunit assembly, is a key player in ribosome production.

Purpose of the Study:

  • To characterize human homologs of SSU processome components.
  • To investigate the impact of chemotherapeutic drugs (Actinomycin D, camptothecin, DRB) on SSU processome function and localization.
  • To elucidate the differential effects of these drugs on nucleolar integrity and ribosome biogenesis.

Main Methods:

  • Characterization of human SSU processome component homologs.
  • Treatment of cells with Actinomycin D, camptothecin, and DRB.
  • Analysis of subcellular localization of SSU processome components using microscopy.
  • Assessment of RNA polymerase I transcription and processome formation.

Main Results:

  • Actinomycin D and DRB treatments caused mislocalization of U3 small nucleolar RNP (snoRNP) away from other SSU processome components.
  • All three drugs affected RNA polymerase I transcription, primarily impacting elongation.
  • Only Actinomycin D treatment led to a significant reduction in overall SSU processome levels.

Conclusions:

  • Different chemotherapeutic drugs exhibit distinct mechanisms in disrupting nucleolar function and ribosome production.
  • The observed effects on SSU processome localization and formation provide insights into drug-induced cellular stress responses.
  • Understanding these differential effects is crucial for comprehending chemotherapy-induced cell death pathways.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...